Compare BBDC & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BBDC | QDEL |
|---|---|---|
| Founded | 2006 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Financial Services | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 879.5M | 1.0B |
| IPO Year | 2006 | 2022 |
| Metric | BBDC | QDEL |
|---|---|---|
| Price | $8.35 | $14.21 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | $9.56 | ★ $28.25 |
| AVG Volume (30 Days) | 776.0K | ★ 1.6M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 11.67% | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ 0.25 | N/A |
| Revenue | N/A | ★ $2,730,200,000.00 |
| Revenue This Year | N/A | $3.51 |
| Revenue Next Year | N/A | $3.86 |
| P/E Ratio | $33.68 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.97 | $9.92 |
| 52 Week High | $9.92 | $35.58 |
| Indicator | BBDC | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 43.65 | 56.63 |
| Support Level | $8.20 | $10.39 |
| Resistance Level | $8.49 | $15.76 |
| Average True Range (ATR) | 0.15 | 0.98 |
| MACD | -0.00 | 0.10 |
| Stochastic Oscillator | 25.93 | 54.27 |
Barings BDC Inc operates as a closed-end, non-diversified investment company and has elected to be treated as a business development company. The company's investment objective is to generate current income by investing directly in privately held middle-market companies to help these companies fund acquisitions, growth, or refinancing. It employs fundamental credit analysis and targets investments in businesses with low levels of cyclicality and operating risk relative to other businesses in this market segment. The holding size of each position will generally be dependent upon a number of factors including total facility size, pricing and structure, and the number of other lenders in the facility.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.